SUN-9221

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameSUN-9221

Drug Alias NameSUN-9221

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsAdrenergic receptor alpha-1 antagonists

TargetsSerotonin 2a (5-HT2a) receptorAdrenergic receptors alpha-1

Therapy Area/IndicationsHypertensionThrombosisMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAsubio

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAsubio

Active IndicationsN/A

Inactive IndicationsHypertensionThrombosisMyocardial Ischemia

ATC CodeN/A